Diagnostic performance of human epididymis protein 4 compared to a combination of biophysical and biochemical markers to differentiate ovarian endometriosis from epithelial ovarian cancer in premenopausal women-Reference-Cited by-同舟云学术

Diagnostic performance of human epididymis protein 4 compared to a combination of biophysical and biochemical markers to differentiate ovarian endometriosis from epithelial ovarian cancer in premenopausal women

Published:2017-10-13 Issue:12 Volume:43 Page:1870-1879
ISSN:1341-8076
Container-title:Journal of Obstetrics and Gynaecology Research
language:en
Short-container-title:J. Obstet. Gynaecol. Res.

Author:

Nikolova Tanja¹^ORCID,Zivadinovic Radomir²,Evtimovska Nina³,Klisarovska Violeta⁴,Stanojevic Marko²,Georgievska Jadranka⁵,Nikolova Natasha¹

Affiliation:

1. Department for Gynecological Oncology; University Clinic of Obstetrics and Gynecology; Skopje Macedonia

2. Department for Gynecological Oncology, Clinic of Obstetrics and Gynecology; University Clinical Center; Nis Serbia

3. Biochemical Laboratory; University Clinic of Oncology and Radiotherapy; Skopje Macedonia

4. Department for Gynecological Oncology; University Clinic of Oncology and Radiotherapy; Skopje Macedonia

5. Department for Urgent Gynecology; University Clinic of Obstetrics and Gynecology; Skopje Macedonia

Publisher

Wiley

Subject

Obstetrics and Gynaecology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jog.13466/fullpdf

Reference25 articles.

1. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities;Nisolle;Fertil Steril,1997

2. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: Possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary;Sato;Cancer Res,2000

3. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients;Earle;J Natl Cancer Inst,2006

4. The role of CA-125 in the management of ovarian cancer;Markman;Oncologist,1997

5. Benign conditions associated with raised serum CA-125 concentration;Buamah;J Surg Oncol,2000

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation and management of endometriosis;Climacteric;2023-04-13

2. HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients;BMC Cancer;2022-07-30

3. Diagnostic Models Combining Clinical Information, Ultrasound and Biochemical Markers for Ovarian Cancer: Cochrane Systematic Review and Meta-Analysis;Cancers;2022-07-26

4. Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women;Cochrane Database of Systematic Reviews;2022-07-26

5. Value of the Copenhagen index in the diagnosis of malignant adnexal tumors: A meta‐analysis;International Journal of Gynecology & Obstetrics;2022-07-04